newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

HAYWARD, Calif., March 10, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, t